Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Occult Cancer”

287 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 287 results

Testing effectiveness (Phase 2)Ended earlyNCT02196168
What this trial is testing

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT01754896
What this trial is testing

Pilot Evaluation of Fecal Immunologic Test (FIT) in Ontario

Who this might be right for
Colorectal Cancer
Sunnybrook Health Sciences Centre 28
Not applicableStudy completedNCT01671696
What this trial is testing

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy

Who this might be right for
Cardiovascular Disease
Connecticut Children's Medical Center 80
Not applicableStudy completedNCT06336694
What this trial is testing

A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
First Affiliated Hospital, Sun Yat-Sen University 302
Early research (Phase 1)Study completedNCT01944930
What this trial is testing

Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases

Who this might be right for
Gastrointestinal and Gynecologic Malignancies
Lahey Clinic 23
Not applicableUnknownNCT01279330
What this trial is testing

Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

Who this might be right for
Colorectal Cancer
University of Paris 5 - Rene Descartes 1,569
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Temporarily pausedNCT07071961
What this trial is testing

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Who this might be right for
Colorectal CancerRegorafenibHigh Risk Patients
M.D. Anderson Cancer Center 16
Very early researchStudy completedNCT01364454
What this trial is testing

General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening

Who this might be right for
Colorectal Cancer
Paris 12 Val de Marne University 8,140
Not applicableStudy completedNCT00812942
What this trial is testing

Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy

Who this might be right for
Colorectal Cancer
Istituto Superiore di Sanità 9,889
Not applicableLooking for participantsNCT05963464
What this trial is testing

RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

Who this might be right for
Breast CancerOccult Breast Carcinoma
European Institute of Oncology 300
Not applicableStudy completedNCT00482872
What this trial is testing

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 400
Testing effectiveness (Phase 2)Ended earlyNCT00646659
What this trial is testing

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Testing effectiveness (Phase 2)Study completedNCT00873119
What this trial is testing

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Who this might be right for
Carcinoma of Unknown Primary
Valerio Therapeutics 89
Not applicableStudy completedNCT01998009
What this trial is testing

Study of In-home Tests for Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centers for Disease Control and Prevention 1,382
Testing effectiveness (Phase 2)Study completedNCT00503997
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 42
Not applicableUnknownNCT04856423
What this trial is testing

Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
Shandong University 6,000
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00509665
What this trial is testing

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Medical University of South Carolina 18
Load More Results